Put Americans First by Ending Global Freeloading
AMERICA FIRST POLICY INSTITUTE
« Patients with chronic conditions and other debilitating diseases can access lifesaving prescription drugs because drug manufacturers and American health agencies invest billions of dollars to develop new medicines.
« Other wealthy countries pay artificially lower prices for prescription drugs, which deprives drug manufacturers of billions of dollars that are critical to developing lifesaving medications to treat chronically ill patients. Other countries pay just 24 percent of the price that Americans pay for brand-name prescription drugs.
« Policymakers can expand access to pharmaceutical treatments for sick patients by pressuring wealthy countries to end freeloading practices. Greater pharmaceutical options would also lower costs for Americans by increasing competition and helping sick patients avoid costly hospital visits.